Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 3 completed trials

    Completion Rate
    100%(3/3)
    Active Trials
    0(0%)
    Results Posted
    67%(2 trials)

    Phase Distribution

    Phase 2
    1
    25%
    Phase 3
    1
    25%
    Early Phase 1
    1
    25%
    Not Applicable
    1
    25%

    Phase Distribution

    1

    Early Stage

    1

    Mid Stage

    1

    Late Stage

    Phase Distribution4 total trials
    Early Phase 1First-in-human
    1(25.0%)
    Phase 2Efficacy & side effects
    1(25.0%)
    Phase 3Large-scale testing
    1(25.0%)
    N/ANon-phased studies
    1(25.0%)

    Highest Phase Reached

    Phase 3

    Trial Status & Enrollment

    Completion Rate

    100.0%

    3 of 3 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    4

    all time

    Status Distribution
    Completed(3)
    Other(1)

    Detailed Status

    Completed3
    unknown1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    4
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Phase 3

    Trials by Phase

    Early Phase 11 (25.0%)
    Phase 21 (25.0%)
    Phase 31 (25.0%)
    N/A1 (25.0%)

    Trials by Status

    completed375%
    unknown125%

    Recent Activity

    0 active trials
    Showing 4 of 4
    completedearly_phase_1

    Characterization of Tissue-Specific Immune Responses to Bronchoscopic Instillation of Mycobacterial Antigens Into the Human Lung

    NCT05027958
    unknownphase_3

    Efficacy of Cryotherapy Combined With Intralesional Tuberculin PPD Versus Intralesional Tuberculin PPD in Treatment of Multiple Common Warts

    NCT04288817
    completedphase_2

    Leprosy Skin Test Antigens Trial

    NCT00128193
    completednot_applicable

    Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection

    NCT00000955

    Clinical Trials (4)

    Showing 4 of 4 trials
    NCT05027958Early Phase 1

    Characterization of Tissue-Specific Immune Responses to Bronchoscopic Instillation of Mycobacterial Antigens Into the Human Lung

    Completed
    NCT04288817Phase 3

    Efficacy of Cryotherapy Combined With Intralesional Tuberculin PPD Versus Intralesional Tuberculin PPD in Treatment of Multiple Common Warts

    Unknown
    NCT00128193Phase 2

    Leprosy Skin Test Antigens Trial

    Completed
    NCT00000955Not Applicable

    Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection

    Completed

    All 4 trials loaded

    Drug Details

    Intervention Type
    Varies by study
    Total Trials
    4